ADLAI NORTYE Trademark

Trademark Overview


On Wednesday, October 20, 2021, a trademark application was filed for ADLAI NORTYE with the United States Patent and Trademark Office. The USPTO has given the ADLAI NORTYE trademark a serial number of 79334074. The federal status of this trademark filing is REGISTERED as of Tuesday, June 27, 2023. This trademark is owned by Hangzhou Adlai Nortye Biopharma Co., Ltd.. The ADLAI NORTYE trademark is filed in the Pharmaceutical Products category with the following description:

Chemico-pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; injectable pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; injectable pharmaceutical solutions for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; troche, namely, medicated lozenges; medicines based on biologically active substances for treatment of tumor, immune, and metabolic related diseases and disorders; blood substitutes for medical and veterinary use; medicines for human purposes for treatment of tumor, immune, and metabolic related diseases and disorders; drugs for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; biological preparations for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; stem cells for medical purposes; biochemical drug, namely, biochemical pharma...
adlai nortye

General Information


Serial Number79334074
Word MarkADLAI NORTYE
Filing DateWednesday, October 20, 2021
Status700 - REGISTERED
Status DateTuesday, June 27, 2023
Registration Number7088904
Registration DateTuesday, June 27, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements


Goods and ServicesChemico-pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; injectable pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; injectable pharmaceutical solutions for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; troche, namely, medicated lozenges; medicines based on biologically active substances for treatment of tumor, immune, and metabolic related diseases and disorders; blood substitutes for medical and veterinary use; medicines for human purposes for treatment of tumor, immune, and metabolic related diseases and disorders; drugs for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; biological preparations for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; stem cells for medical purposes; biochemical drug, namely, biochemical pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders
Translation of Words in MarkThe English translation of "ADLAI" in the mark is "Gods is just". The word "NORTYE" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHangzhou Adlai Nortye Biopharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameHangzhou Adlai Nortye Biopharma Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameHangzhou Adlai Nortye Biopharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Tuesday, October 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 28, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 27, 2023FINAL DISPOSITION PROCESSED
Wednesday, September 27, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 27, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 27, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, April 13, 2023NOTIFICATION PROCESSED BY IB
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 22, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 8, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, March 8, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 8, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, March 8, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, February 23, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 12, 2022REFUSAL PROCESSED BY IB
Wednesday, August 24, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 24, 2022REFUSAL PROCESSED BY MPU
Saturday, July 30, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, July 29, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 27, 2022ASSIGNED TO EXAMINER
Tuesday, March 1, 2022APPLICATION FILING RECEIPT MAILED
Friday, February 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 24, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB